Article
Use of the Polo-like kinase 4 (PLK4) inhibitor centrinone to investigate intracellular…
medRxiv · 2020 · Byrne, D. P.; Clarke, C. J.; Brownridge, P.; Kalyuzhnyy, A.; Perkins, S.; Campbell, A.; Mason, D.; Jones, A. R.; Eyers, P. A.; Eyers, C. E.
Key facts
| Title | Use of the Polo-like kinase 4 (PLK4) inhibitor centrinone to investigate intracellular signaling networks using SILAC-based phosphoproteomics |
|---|---|
| First author | Byrne, D. P.; Clarke, C. J.; Brownridge, P.; Kalyuzhnyy, A.; Perkins, S.; Campbell, A.; Mason, D.; Jones, A. R.; Eyers, P. A.; Eyers, C. E. |
| Journal | medRxiv |
| Published | May 24, 2020 |
| DOI | 10.1101/2020.05.22.110767 |
| Devices mentioned | BK110039, K103302 |
| Product codes mentioned | KIT, MVU, NDS, NJT, OOI, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1